Characterization and human osteoblastic proliferation- and differentiation-stimulatory effects of phosphatidylcholine liposomes-encapsulated propranolol hydrochloride

Meiho University Institutional Repository > 健康暨護理學院 > 美容系 > 期刊論文 > Item 987654321/2577

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.meiho.edu.tw/ir/handle/987654321/2577

题名:	Characterization and human osteoblastic proliferation- and differentiation-stimulatory effects of phosphatidylcholine liposomes-encapsulated propranolol hydrochloride
作者:	Benjamin Teong;Shyh-Ming Kuo;Chung-Hwan Chen;Yu-Kuei Chen
贡献者:	健康暨護理學院
日期:	2014
上传时间:	2014-10-17T03:52:31Z (UTC)
摘要:	DMPC and DSPC liposomes were prepared via thin film hydration method followed by sonication. Propranolol solution was incorporated into liposomes at hydration stage. TEM images showed the sizes of DSPC and DMPC were around 88 and 137 nm, respectively. The highest encapsulation ratio of propranolol was approximately 70% using DSPC/CHO/OCT liposomes, which release the drug over 60% in 24 h and reached 100% in 48 h. Both propranolol (10−8–10−6 M) and DSCP liposomes-encapsulated propranolol showed over 1.5-fold increases in the proliferation of human osteoblastic cells hFOB1.19 while differentiation of the cells was approximately doubled by plain and liposomal propranolol, indicating that the stimulatory effects of liposomal propranolol are similar with those of propranolol on human osteoblastic hFOB1.19 cells. The phosphatidylcholine liposomes-encapsulated propranolol prepared in this study potentially possesses anabolic effects in vivo and is also a promising anti-osteoporotic agent in future.
關聯:	Bio-Medical Materials and Engineering
显示于类别:	[美容系] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
BME997 author version.pdf		336Kb	Adobe PDF	0	检视/开启

检视Licence

在MUIR中所有的数据项都受到原著作权保护.